VANDA PHARMACEUTICALS INC's ticker is VNDA and the CUSIP is 921659108. A total of 111 filers reported holding VANDA PHARMACEUTICALS INC in Q2 2015. The put-call ratio across all filers is 0.52 and the average weighting 0.2%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q4 2016 | $2,346,000 | -4.6% | 147,091 | -0.5% | 0.00% | 0.0% |
| Q3 2016 | $2,459,000 | +48.8% | 147,757 | +0.0% | 0.00% | +50.0% |
| Q2 2016 | $1,653,000 | +31.8% | 147,700 | -1.5% | 0.00% | 0.0% |
| Q1 2016 | $1,254,000 | -10.9% | 149,999 | -0.8% | 0.00% | 0.0% |
| Q4 2015 | $1,407,000 | -17.1% | 151,152 | +0.5% | 0.00% | 0.0% |
| Q3 2015 | $1,697,000 | -11.2% | 150,409 | -0.1% | 0.00% | 0.0% |
| Q2 2015 | $1,911,000 | +98.0% | 150,622 | +45.2% | 0.00% | +100.0% |
| Q1 2015 | $965,000 | -40.5% | 103,719 | -8.4% | 0.00% | -50.0% |
| Q4 2014 | $1,621,000 | +57.2% | 113,210 | +14.0% | 0.00% | +100.0% |
| Q3 2014 | $1,031,000 | -35.2% | 99,335 | +1.0% | 0.00% | -50.0% |
| Q2 2014 | $1,591,000 | +6.6% | 98,346 | +7.0% | 0.00% | 0.0% |
| Q1 2014 | $1,493,000 | +31.9% | 91,877 | +0.8% | 0.00% | 0.0% |
| Q4 2013 | $1,132,000 | +11.0% | 91,178 | -2.1% | 0.00% | 0.0% |
| Q3 2013 | $1,020,000 | +65.6% | 93,171 | +22.3% | 0.00% | +100.0% |
| Q2 2013 | $616,000 | – | 76,213 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Consonance Capital Management LP | 4,658,759 | $121,733,000 | 8.95% |
| Palo Alto Investors LP | 4,155,670 | $108,588,000 | 5.78% |
| Stonepine Capital Management, LLC | 220,848 | $5,771,000 | 5.07% |
| Birchview Capital, LP | 80,000 | $2,090,000 | 1.98% |
| EAM Global Investors LLC | 75,310 | $1,968,000 | 1.08% |
| Atika Capital Management LLC | 130,000 | $3,397,000 | 1.00% |
| EAM Investors, LLC | 110,806 | $2,895,000 | 0.79% |
| UNIVERSITY OF NOTRE DAME DU LAC | 97,521 | $2,548,000 | 0.62% |
| ALGERT GLOBAL LLC | 76,204 | $1,991,000 | 0.56% |
| 361 CAPITAL LLC | 85,885 | $2,244,000 | 0.46% |